Search - tctmd.com

Displaying 221 - 240 of 750

Sort: Relevancy | Date

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Subclinical HFpEF Common in Patients Undergoing AF Ablation

News Daily News

Subclinical HFpEF Common in Patients Undergoing AF Ablation

September 08, 2023

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

August 25, 2023

What’s Going to Be Hot at ESC 2023?

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

August 15, 2023

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

August 09, 2023

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

August 08, 2023

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

August 01, 2023

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

More Data Show Redlining’s Lasting Impact on CVD Risk

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

July 14, 2023

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

News Daily News

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

July 06, 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

June 29, 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

June 28, 2023

ESH Upgrades Denervation, Details Comorbidities in New Hypertension Guideline

News Daily News

ESH Upgrades Denervation, Details Comorbidities in New Hypertension Guideline

June 27, 2023

Wintertime Brings Increased IHCA Risk, US Data Show

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

June 26, 2023

FDA Approves Colchicine for Decreasing CV Events

News Daily News

FDA Approves Colchicine for Decreasing CV Events

June 20, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.